Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
FRANCE – Evotec SE has officially launched the construction of its J.POD biologics manufacturing facility at its Campus Curie in Toulouse, France. Construction of a biologics manufacturing facility commenced on…
Read More
FRANCE – bioMérieux, a key player in the global in vitro diagnostics arena, has partnered with BrightInsight to develop and market a digital clinical decision support tool for multiple disease…
Read More
ETHIOPIA – The African Center for Disease Control and Prevention (Africa CDC) has secured a US$2.4M grant from France to bolster outbreak preparedness and response to high consequence infectious diseases…
Read More
SUDAN – The Sudanese Ministry of Health and Médecins Sans Frontières (MSF), commonly known as Doctors Without Borders, have partnered to assist healthcare professionals working at a clinic in South…
Read More
FRANCE- BioMérieux has announced that its SPECIFIC REVEAL® Rapid Antimicrobial Susceptibility Test (AST) System has received the Breakthrough Device Designation from the U.S. Food and Drug Administration. This designation is…
Read More
FRANCE- Sanofi has decided to stop developing amcenestrant, a once-promising breast cancer medication, after a second unsuccessful clinical trial, striking a setback to its pipeline of potential new medicines. The…
Read More
FRANCE – French-based investment firm ArchiMed has completed its previously announced acquisition of US-based medical devices maker Natus Medical for a total consideration of US$1.2bn. ArchiMed is exclusively focused on…
Read More
FRANCE – French Pharma giant Sanofi has halted development of lademirsen, discovered by Regulus Therapeutics, after the program failed a Phase II interim analysis. Sanofi added that the move was…
Read More
FRANCE – Inserm Transfert, the private subsidiary of the French National Institute of Health and Medical Research (Inserm), has invetsted in AMF-regulated investment company AdBio Partners’ second fund – AFB…
Read More
SINGAPORE – French pharmaceutical company, Sanofi has begun construction on the first of two so-called Evolutive Vaccine Facilities (EVFs) it is constructing with a total investment of 900 million euros…
Read More